▁skeletal
▁tiss
▁sensi
▁avail
▁metast
▁glut
ronch
▁decreased
▁exer
▁symptom
tical
ffin
▁tas
▁proximal
uretic
▁differe
tivity
▁lesion
oglobin
qui
▁cann
▁stimulation
▁distal
▁antic
ocl
▁valve
▁stenosis
▁bir
estion
lusion
▁chloride
Ig
treated
tention
▁excretion
▁beha
ults
ochrome
LV
bral
▁interleukin
▁ach
generation
▁dopamine
odium
▁inhibit
▁filtration
▁throm
▁hepat
▁adrenal
▁criter
▁steroid
▁blot
▁correlated
▁lymphocytes
tion
emia
dominal
▁progres
assi
▁cardiac
▁retur
▁clinically
aline
▁wee
imin
▁graft
odies
osomal
ration
▁trig
▁supple
▁mono
▁glyc
▁concentrations
tiv
▁potent
tinu
▁clus
iotensin
▁hormone
hyd
▁detectable
ocar
ignific
▁identif
ostic
resist
▁estrogen
▁resul
▁predominant
▁underwent
nec
iatric
▁kinase
ocytosis
crib
trac
▁reversed
assium
▁hep
▁differen
containing
▁sampl
▁cervical
▁provid
▁bladder
plasia
▁assay
▁antibody
sively
olytic
otox
tained
trum
▁suppressed
thyl
▁doses
▁systemic
▁ischemia
monary
lood
▁lipoprotein
▁Addition
itone
ylated
▁membran
rosis
tox
odil
mediately
▁Treatment
duction
amus
▁fetal
▁diastolic
alian
pecific
▁elevation
▁systolic
produc
ficial
▁heterogene
▁kidne
▁plas
tive
feren
▁inflamm
idne
iol
otyp
protein
ergic
▁quantit
▁mmol
tensive
oglobulin
ipit
ectom
toc
otypes
adrenergic
anine
▁soluble
▁hypothe
▁infec
eared
taining
spective
▁lact
gluc
dose
▁markedly
▁chan
▁stren
▁lymph
associated
▁intake
▁hemat
▁isolates
▁effic
yro
geal
▁albumin
▁bypass
▁predic
▁precur
▁detec
ovascular
ocrine
▁immun
▁melan
▁inten
anding
ocaine
▁assessed
entif
▁embry
enic
ucle
▁onset
▁cytochrome
gesterone
positive
vity
▁hypot
onstric
▁potenti
teroid
▁thromb
scher
trol
tors
▁infarction
▁lipid
▁antigen
siveness
▁HLA
▁restric
genic
▁atrial
▁venti
▁statistically
▁RA
▁objec
▁gluc
ergy
scherichia
▁dors
▁incub
oxygen
▁Patients
▁induc
▁atten
DNA
▁responsiveness
tance
imens
▁characteris
▁intra
▁previ
▁experim
ionic
quid
▁infar
trogen
▁pancre
▁confir
▁respiratory
tro
osterone
tiz
▁insulin
lux
ologic
▁acet
tively
veness
▁diets
lym
▁substanti
acin
▁mice
idase
▁contrib
▁cate
iotic
▁infants
▁assays
▁angi
▁physici
mature
oscop
▁markers
▁calcium
▁metabolism
orac
▁predominantly
▁malignant
▁hydrox
▁antibodies
gative
▁decreases
sia
▁ischemic
tility
▁elimin
ygen
▁sten
▁chol
▁amo
▁microscop
ilic
▁examin
ilateral
▁resistant
▁phenotype
▁testosterone
ffec
roph
▁cereb
▁alcoh
▁injur
▁adequ
▁rhy
immun
tric
▁intest
▁aspec
mia
▁consis
▁randomized
▁mortality
▁pancreatic
▁struc
entral
▁cerv
chol
▁glucose
▁deli
▁strains
▁electr
▁suppres
rox
▁stu
tension
▁bran
▁Escherichia
▁physiological
▁reac
▁cholesterol
▁hypo
methyl
tur
ogenous
osom
armac
seud
▁localized
▁synthesized
rease
▁biopsy
▁gon
▁fatty
▁carcinoma
trib
ints
▁specificity
utaneous
▁tach
▁extre
ycin
▁consecu
olol
▁membranes
▁glomerular
astolic
▁Hg
▁induction
▁progn
▁tran
▁selective
▁rats
▁acute
atitis
▁lesions
▁gestation
▁scre
▁gastro
ylase
▁coli
▁antagonist
▁neph
▁pneum
tisol
▁ester
rocy
erative
▁elec
mented
▁statis
▁hypertensive
▁unchanged
echn
▁vaccin
▁perip
▁exhibited
▁iso
▁decreas
tensin
lob
rhy
▁expres
mol
loid
▁eryth
tory
vic
▁malign
▁polym
▁reduc
ortic
lobin
OH
▁undergo
itamin
till
osal
▁stimul
mentation
▁seroton
▁biochemical
▁spon
▁IgG
opo
▁reactivity
▁fas
▁neurop
▁sulfate
▁cardi
▁excre
piratory
▁serum
▁micros
reas
▁immunos
▁vitro
ectin
acr
oprotein
▁extrac
▁shor
▁cyclo
▁agonist
▁injected
▁simult
▁trac
epti
pine
▁diabe
pecially
iae
▁endogenous
otrop
▁administered
orrh
sive
keletal
▁suscepti
turb
▁studi
▁pati
▁retic
▁oste
▁extracts
▁coronary
▁reflex
▁maternal
▁vascular
▁symp
angl
▁complications
▁arter
effec
▁enzymes
▁enzyme
▁progesterone
▁respec
asal
▁gastric
▁metabolic
Hg
plas
aturation
▁cyt
▁rati
ocortic
▁urine
orption
ensi
▁memb
▁intrac
▁leuk
▁glycoprotein
▁LT
▁uptake
▁posi
acet
olysis
tis
viron
illary
ociated
▁underst
ayed
▁severity
orpor
▁nitro
▁renal
BV
urther
▁dysfunction
idine
▁remo
▁sulf
natal
▁hypox
omal
▁pretreatment
pir
opro
affec
eded
▁arterial
▁neutroph
▁bacterial
▁effec
resistant
▁cultured
▁injec
sion
▁tes
▁diffic
jec
ichia
▁persis
▁TSH
▁immunoglobulin
ctive
▁ery
▁vein
▁differenti
▁molecule
erate
coh
▁repor
fusion
▁hetero
mental
tum
▁neon
▁sple
eptide
illin
▁peripheral
entricular
▁hypertension
▁ventricular
ecu
cepti
fec
▁regression
sess
▁prevalence
mend
lyce
▁ratios
lyc
▁efficacy
▁granul
▁polyp
cine
▁transi
▁incidence
tural
▁enti
▁comple
hydrox
rine
vely
terol
▁acids
▁conduc
▁ure
yroid
▁thyroid
▁cerebral
stim
▁vesicles
inally
ymp
▁smo
sych
▁dorsal
tically
▁challen
▁sero
▁carcin
▁analyses
▁bloc
▁LV
▁clon
operative
duce
▁inflammatory
▁unaffected
tial
▁selec
▁antagon
▁poten
▁suppression
▁attemp
osyl
leu
▁exten
zyme
▁construc
▁impaired
▁cortic
▁LDL
ociation
inic
ogenic
▁pituitary
tage
▁repres
▁infusion
▁gland
onary
▁injections
▁deficiency
▁agonists
▁propor
ethyl
leukin
▁lar
▁preparations
▁hydroly
reast
▁Tran
▁valu
▁plasm
▁histamine
opathy
▁contraction
ectomy
tics
ranolol
▁protoc
▁gonad
▁vitamin
▁retin
▁angiotensin
ocyte
tured
lycer
opres
▁inhibitor
▁combin
dition
omycin
▁quanti
▁heparin
DH
▁possi
▁requi
▁IgM
rents
uble
okine
gth
avage
icin
▁Bec
terone
radi
▁adren
owever
▁myocardial
▁inhibitory
▁preven
▁attenu
tif
▁intestinal
acchar
treatment
ocyt
▁abnormalities
▁dehyd
onucle
▁compounds
▁initiation
itant
▁pharmac
▁prostaglandin
itro
▁abnormal
▁benz
tero
▁carbohyd
adren
▁monit
▁pH
▁ovarian
▁receptor
▁transient
▁reproduc
tially
▁produc
bumin
ocytes
▁suppor
EG
▁recom
Ca
cence
amide
▁surgical
▁infections
elec
▁pulmonary
uted
tingu
▁nec
loro
otassium
▁intravenous
eric
▁hepatic
▁untreated
▁attrib
▁numb
▁affec
▁ranged
utions
induced
esti
kely
▁quantitative
▁chemotherapy
▁Ig
▁techniqu
▁aden
tact
dle
▁hypoth
▁hepatitis
▁defec
tures
▁cys
▁induce
tral
tic
▁chlor
olesterol
▁tumors
▁bronch
▁perox
▁resec
▁mucosa
▁impair
▁glomer
▁venous
idation
▁actin
▁tox
▁sodium
▁ana
ticular
▁depres
▁recor
▁hypertro
▁amin
▁biop
reased
▁hypothal
ditions
▁occurrence
▁exis
eration
oyl
lier
ture
ximal
▁receptors
▁establ
erence
tions
▁dex
▁therapeutic
atients
▁agon
▁elic
▁panc
tation
crip
▁basal
▁guinea
▁antagonists
otor
▁fractions
▁pyr
▁compart
erated
accharide
echan
▁dietary
entical
▁kidney
duced
▁reactive
▁spontaneous
▁spinal
▁pla
▁muc
oic
▁perfusion
hydro
bility
▁uter
went
▁prolonged
▁diabetic
actin
oxin
tin
phal
olec
▁toxicity
ignificant
▁viral
▁obser
▁ech
oplasm
▁methyl
▁reas
▁discus
tional
scop
▁subjec
▁neonatal
▁phosphate
azole
▁postoperative
▁reflec
▁artery
▁urinary
▁adap
▁reticul
sible
▁bac
▁potassium
tration
phosph
▁subc
▁toge
onate
tice
▁elevated
▁renin
ocardi
▁ultras
erent
tein
▁intraven
▁cis
▁lateral
ameth
esic
ardia
▁inhibitors
urine
▁cardiovascular
▁inser
ochemical
▁prol
▁indi
▁increas
lobulin
▁placebo
lec
▁transcription
▁phosph
▁stimulus
tent
ulatory
hyp
osin
ritis
▁sugges
▁tumor
adder
inergic
▁gradi
bly
anol
